Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | GSTK1 | Q9Y2Q3 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8523520 | 0.98 | FFAR4 (0.42) | FFAR4FFAR1LMNATSHRNFKB1 | |
| SCHEMBL11021433 | 0.92 | GSTK1 (0.44) | FFAR4FFAR1LMNATSHRNFKB1 | |
| SCHEMBL28688931 | 0.91 | LMNA (0.44) | FFAR4FFAR1LMNATSHRNFKB1 | |
| SCHEMBL21633939 | 0.89 | LMNA (0.42) | FFAR4FFAR1LMNATSHRNFKB1 | |
| SCHEMBL8661641 | 0.88 | FFAR1 (0.55) | FFAR4FFAR1LMNATSHRNFKB1 | |
| SCHEMBL28830391 | 0.88 | FFAR1 (0.55) | FFAR4FFAR1LMNATSHRNFKB1 | |
| SCHEMBL28075980 | 0.88 | FFAR1 (0.55) | FFAR4FFAR1LMNATSHRNFKB1 | |
| SCHEMBL9875093 | 0.88 | FFAR1 (0.55) | FFAR4FFAR1LMNATSHRNFKB1 | |
| SCHEMBL28076073 | 0.88 | FFAR1 (0.55) | FFAR4FFAR1LMNATSHRNFKB1 | |
| SCHEMBL28076156 | 0.88 | FFAR1 (0.55) | FFAR4FFAR1LMNATSHRNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8318868-B2 | Isocyanate-containing thermoplastic polyurethane | BASF AKTIENGESELLSCHAFT (DE) | 2012-11-27 | — | — | US | disclosed |
| US-7498379-B2 | Carbodiimides containing urea groups and silyl-groups | BASF AKTIENGESELLSCHAFT (DE) | 2009-03-03 | — | — | US | disclosed |
| US-20080207846-A1 | Isocyanate-Containing Thermoplastic Polyurethane | BASF AKTIENGESELLSCHAFT PATENTS, TRADEMARKS AND LICENSES (DE) | 2008-08-28 | — | — | US | disclosed |
| US-20080015294-A1 | Carbodiimides Containing Urea Groups and Silane Groups | BASF AKTIENGESELLSCHAFT (DE) | 2008-01-17 | — | — | US | disclosed |
| US-20070208158-A1 | Polyurethane Containing Carbodiimides | BASF AKTIENGESELLSCHAFT (DE) | 2007-09-06 | — | — | US | disclosed |
| EP-0922552-B1 | Process for continuous production of granules of thermoplastic polyurethanelastomers | BASF AG (DE) | 2004-09-22 | — | — | EP | disclosed |
| EP-0922552-A1 | Process for continuous production of granules of thermoplastic polyurethanelastomers | BASF AKTIENGESELLSCHAFT (DE) | 1999-06-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080015294-A1 | Carbodiimides Containing Urea Groups and Silane Groups | HRH4, HRH3, OXER1 | FFAR4 443/4885FFAR1 226/4885LMNA 2144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.